View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

IDE joined Global Bioequivalance Harmonization Initiative

For several years now, the European Federation for Pharmaceutical Sciences (EUFEPS), with its Network on Bioavailability and Biopharmaceutics (BABP) in the lead, has worked toward harmonizing the requirements for bioequivalence assessment.

This goal was encouraged from the beginning by the European Medicines Agency (EMA) as well as the US Food and Drug Administration (FDA). To support the intended process of global harmonization scientifically, a series of international conferences was started by EUFEPS in collaboration with AAPS.

All conferences were characterized by open discussions and constructive exchange between regulatory scientists, academia and industry.

Our manager Prof Dr Atilla Hincal has been invited by AAPS / EUFEPS for Welcome and Introduction speech on behalf of EUFEPS. He participated Global Bioequivalance Harmonization Initiative:4th International Workshop on 12-13 December 2019 in Bethesda/USA.

For more information, please fill out the enquiry form attached to this page.

İDE® was established in 1998 as a “Contract Research Organisation” providing integrated services.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology